GlycoPath Appoints Kathy Phlegar as CEO
CHARLESTON, S.C., Feb. 15, 2023 /PRNewswire/ -- GlycoPath Inc., developer of advanced bioanalytical assays based on its proprietary GlycoTyper™ immunoaffinity technology, has appointed Kathy Phlegar as CEO. This change comes as the company continues to …